While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
